|2nd June 2020||Michael Sardano||1,483||Payment by withholding||$3.05||$4,523.15|
|2nd June 2020||Javier Rampolla||1,186||Payment by withholding||$3.05||$3,617.30|
|2nd June 2019||Michael Sardano||1,948||Payment by withholding||$5.59||$10,889.32|
|2nd June 2019||Arthur Levine||14,628||Payment by withholding||$5.59||$81,770.52|
|22nd March 2019||Kalman Fishman||173||Open or private sale||$7.50||$1,297.50|
|22nd March 2019||Stephen Brad Cohen||595||Open or private sale||$7.50||$4,462.50|
|22nd March 2019||Richard Golin||492||Open or private sale||$7.50||$3,690.00|
|21st March 2019||Richard Golin||509||Open or private sale||$7.50||$3,817.50|
|20th March 2019||Richard Golin||5,943||Open or private sale||$7.56||$44,929.08|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Sensus Healthcare's SRT-100 is a photon x-ray low energy superficial radiotherapy system. It provides patients an alternative to surgery for treating basal cell and squamous cell skin cancers and other skin conditions.